We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DAAQ:NASDAQDigital Asset Acquisition Corp. Analysis

Data as of 2026-03-28 - not real-time

$10.23

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Digital Asset Acquisition Corp. (DAAQ) is trading at $10.23, essentially flat on its 20‑day and 50‑day SMAs (10.23) but just below the 200‑day SMA (10.28), indicating a lack of clear directional bias. The RSI sits at 52.6, suggesting neutral momentum, while the MACD histogram is marginally negative and the signal line is flagged as bearish, adding a slight downside tilt. Volume has been decreasing, with today’s 943 shares far under the 10‑day average of 24,440, raising concerns about liquidity. On the valuation side, the trailing P/E of 40.9 vastly exceeds the industry average of 16, and a negative price‑to‑book ratio (‑40.3) reflects a book value deficit, underscoring an overvalued profile. The company carries no debt, no dividend, and negligible cash relative to its market cap, while operating cash flow is negative, highlighting weak fundamentals.
Risk‑adjusted metrics show an ultra‑low beta (0.03) and sub‑1% 30‑day volatility, which limits market‑wide price swings but does not offset the liquidity strain, sector uncertainty of a SPAC‑type shell, and the regulatory scrutiny that often accompanies such entities.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • Bearish MACD signal
  • Decreasing volume and liquidity pressure
  • Price marginally below 200‑day SMA

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Neutral RSI indicating no strong momentum
  • Low beta limiting broader market impact
  • Potential SPAC merger catalyst

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • High overvaluation relative to industry peers
  • Negative book value and zero earnings
  • Uncertainty around future acquisition target

Key Metrics & Analysis

Financial Health

P/E Ratio40.9
ROE4.96%
ROA-0.27%
P/B Ratio-40.3
Op. Cash Flow$-2183
Industry P/E16.0

Technical Analysis

TrendNeutral
RSI52.6
Support$10.22
Resistance$10.24
MA 20$10.23
MA 50$10.22
MA 200$10.28
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.03
Volatility0.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.